Uterine smooth muscle targets

Uterine smooth muscle targets refer to a diverse group of receptors, ion channels, and enzymes located within the myometrium that regulate uterine tone and contractility [StatPearls, 2023]. Key molecular targets include the oxytocin receptor (OXTR), prostaglandin receptors (such as PTGFR and PTGER3), and beta-2 adrenergic receptors (ADRB2), alongside L-type voltage-gated calcium channels [PubMed, 2020]. These targets are therapeutically modulated to either induce labor and manage postpartum hemorrhage (oxytocics) or to delay preterm birth (tocolytics) [NIH, 2022]. The physiological response is primarily mediated through the regulation of intracellular calcium concentrations and the activation of myosin light chain kinase, which drives the interaction between actin and myosin filaments [UniProt, 2024]. Pharmacological intervention in this system is critical for managing obstetric complications, though it requires careful monitoring due to potential systemic effects on the maternal cardiovascular system and fetal development [Mayo Clinic, 2023]. Understanding the signaling pathways of these uterine targets is essential for developing more selective agents with improved safety profiles for maternal-fetal medicine [Journal of Clinical Investigation, 2021].

Other names

Myometrial targetsUterine contractile targetsTocolytic targetsOxytocic targetsUterine smooth muscle receptors

Modulation of intracellular calcium levels and myosin light chain phosphorylation through the agonism or antagonism of G protein-coupled receptors (e.g., OXTR, ADRB2) and inhibition of ion channels (e.g., L-type calcium channels) or enzymes (e.g., COX) to regulate myometrial tone.